Itecho Health appoints new board chair

Leeds-based medtech company Itecho Health has appointed Sir David Haslam as chair of the board as it continues its mission to transform care for people with long-term conditions.

Sir David is the former chair of NICE and has held senior leadership roles at the Royal College of General Practitioners, the British Medical Association and the Academy of Medical Royal Colleges. 

He was awarded a CBE in 2004 and was knighted in 2018 for services to NHS leadership.

Sir David said: “I’m really honoured to be joining Adrian and the team.  

“This is an exciting time for the company and there has never been a more important time to support brilliant innovative companies to change the way healthcare is delivered.  

“When I wrote my book Side Effects in 2022, I set down how I believed that our healthcare system had lost its way and how I believed that we can fix it. 

“It’s time for companies such as Itecho to be supported as part of that solution and I can’t wait to get started.”

Itecho, based at Nexus at the University of Leeds, partners with NHS Trusts, leading UK universities and patient charities, and is exploring expansion into international markets including the US.

Dr Adrian Brown, founder and chief executive of Itecho Health, added: “We are delighted that Sir David has chosen to join us on our mission.  

“His leadership, vision and healthcare expertise both here and globally will be of huge benefit to us as we continue to drive the health innovation agenda forward – an area which is much talked about but still needs to be truly delivered.  

“Itecho Health’s Ascelus platform supports both the prevention and treatment of long-term conditions. 

“It has been developed with both patients and clinicians, and Sir David’s guidance and his personal advocacy for services to be patient-centric will help us build on the foundations that we’ve built here and overseas and truly unlock the power of digitisation in healthcare.”

Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →